GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zoetis Inc (MIL:1ZTS) » Definitions » EV-to-FCF

Zoetis (MIL:1ZTS) EV-to-FCF : 38.68 (As of Dec. 13, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Zoetis EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Zoetis's Enterprise Value is €81,602 Mil. Zoetis's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 was €2,110 Mil. Therefore, Zoetis's EV-to-FCF for today is 38.68.

The historical rank and industry rank for Zoetis's EV-to-FCF or its related term are showing as below:

MIL:1ZTS' s EV-to-FCF Range Over the Past 10 Years
Min: 29.22   Med: 54.09   Max: 73.51
Current: 36.82

During the past 13 years, the highest EV-to-FCF of Zoetis was 73.51. The lowest was 29.22. And the median was 54.09.

MIL:1ZTS's EV-to-FCF is ranked worse than
62.79% of 551 companies
in the Drug Manufacturers industry
Industry Median: 25.85 vs MIL:1ZTS: 36.82

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2024-12-13), Zoetis's stock price is €170.56. Zoetis's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was €4.875. Therefore, Zoetis's PE Ratio (TTM) for today is 34.99.


Zoetis EV-to-FCF Historical Data

The historical data trend for Zoetis's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zoetis EV-to-FCF Chart

Zoetis Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 50.65 49.27 68.31 54.66 58.72

Zoetis Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 56.93 58.72 46.92 39.87 40.41

Competitive Comparison of Zoetis's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Zoetis's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zoetis's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zoetis's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Zoetis's EV-to-FCF falls into.



Zoetis EV-to-FCF Calculation

Zoetis's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=81602.272/2109.697
=38.68

Zoetis's current Enterprise Value is €81,602 Mil.
Zoetis's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €2,110 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zoetis  (MIL:1ZTS) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Zoetis's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=170.56/4.875
=34.99

Zoetis's share price for today is €170.56.
Zoetis's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €4.875.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Zoetis EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Zoetis's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Zoetis Business Description

Comparable Companies
Address
10 Sylvan Way, Parsippany, NJ, USA, 07054
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its us business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Zoetis Headlines

No Headlines